Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
mTOR & rapamycin
Research brief

Review: mTOR as a context-dependent hub linking aging hallmarks and geroprotective interventions

This review describes mTOR as a dynamic signaling hub coordinating nutrient sensing, metabolism and stress responses. It reports causal evidence for lifespan regulation in model organisms, while human data remain mainly associative. Interventions such as autophagy activation, dietary changes, physical activity and senotherapeutics partly converge on mTOR but also use parallel pathways. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The review presents mTOR as a dynamic signaling hub coordinating nutrient sensing, metabolic adaptation and cellular stress responses in aging. [1]

  2. Evidence supports a causal role for mTOR in lifespan regulation in model organisms, while human data remain predominantly associative. [1]

  3. Geroprotective interventions partly converge on mTOR signaling but also engage parallel pathways. [1]

The source at a glance

Study type / format
Review (abstract only)
Population / context
Model organisms and humans discussed in a review of mTOR signaling in aging
Summary based on
Study abstract
Original publication
September 19, 2026

mTOR as hub for nutrient sensing and stress

The review presents a three-section framework in which the mechanistic target of rapamycin (mTOR) pathway acts as a dynamic signaling hub. It integrates nutrient sensing, metabolic adaptation and cellular stress responses, and coordinates multiple biological processes underlying aging. Two complexes, mTORC1 and mTORC2, regulate distinct yet complementary aspects of metabolism, protein balance (proteostasis), autophagy, stress adaptation and tissue homeostasis.

Supporting source [1]

Causal evidence in models, associative human data

According to the review, genetic, experimental and translational studies support a causal role for mTOR signaling in lifespan regulation in model organisms. Human data, by contrast, remain predominantly associative, though biologically consistent. The authors therefore do not claim that modulating mTOR extends human lifespan; they describe it as a context-dependent signaling hub whose precise, tissue-specific modulation may promote healthy aging and support future geroscience-based interventions.

Supporting source [1]

Interventions converge only partly on mTOR

The review lists major geroprotective interventions: autophagy activation, dietary interventions, physical activity and senotherapeutics. These partly converge on mTOR signaling but also engage parallel pathways. This adaptive regulation is described as restoring anabolic-catabolic balance, enhancing stress resilience and improving metabolic flexibility. The authors conclude that mTOR links multiple hallmarks of aging and diverse geroprotective interventions, and should be viewed not as a single therapeutic target but as a context-dependent hub.

Supporting source [1]

How to interpret this

This is an abstract of a review; the full text was not reviewed. The causal lifespan evidence comes from model organisms, and human data are described as predominantly associative. The abstract reports no specific interventions, doses, effect sizes or trial results, and the proposed framework is not a validated therapy.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    mTOR functions as a dynamic signaling hub
  2. Finding 2 ↑

    human data remain predominantly associative
  3. Finding 3 ↑

    partly converge on mTOR signaling but also

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…